- Home
- EFSI vs PRQR Comparison
EFSI vs PRQR Comparison
Compare EFSI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EFSI | PRQR |
|---|---|---|
| Founded | 1881 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.3M | 250.7M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | EFSI | PRQR |
|---|---|---|
| Price | $39.97 | $2.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $39.50 | $8.14 |
| AVG Volume (30 Days) | 17.0K | ★ 672.3K |
| Earning Date | 10-23-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $66,122,000.00 | $18,859,556.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $27.28 | $19.56 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | ★ 3.18 | N/A |
| 52 Week Low | $28.70 | $1.07 |
| 52 Week High | $41.12 | $3.10 |
Technical Indicators
Market Signals| Indicator | EFSI | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 42.91 |
| Support Level | $39.54 | $1.91 |
| Resistance Level | $40.77 | $2.31 |
| Average True Range (ATR) | 0.68 | 0.17 |
| MACD | -0.12 | -0.02 |
| Stochastic Oscillator | 16.15 | 21.74 |
Price Performance
Historical ComparisonAbout EFSI Eagle Financial Services Inc
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.